Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

Mounjaro: type 2 diabetes drug more effective than Ozempic to launch in the UK — here’s what you need to know

By Duane Mellor, Lead for Evidence-Based Medicine and Nutrition, Aston Medical School, Aston University
Craig Russell, Lecturer, Aston University
Srikanth Bellary, Clinical Associate Professor, Diabetes and Endocrinology, Aston University
A new drug to treat type 2 diabetes has been approved for use) in the UK. Tirzepatide (sold under the brand name Mounjaro) could be available for prescription by early 2024 – subject to availability.

Mounjaro is an injectable treatment that helps the body to both control blood glucose (sugars) after meals and regulate appetite. Research into the drug has shown it’s more…The Conversation

Read complete article

© The Conversation -
Subscribe to

Follow us on ...
Facebook Twitter